Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Ichor Partners with DrugSmart Pharmacy & Travel Health Now
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(118)
•••
Comment by Jonnyboy85on Dec 16, 2020 9:52am
127 Views
Post# 32117715

RE:Ichor Partners with DrugSmart Pharmacy & Travel Health Now

RE:Ichor Partners with DrugSmart Pharmacy & Travel Health NowTORONTO, Dec. 16, 2020 /CNW/ - Ichor Blood Services, a private Covid-19 test facilitator based in Calgary, has partnered with DrugSmart Pharmacy and Travel Health Now to add brick and mortar specimen collection sites in Ontario for private Covid-19 PCR testing. DrugSmart and Travel Health Now locations will exclusively offer StageZero Life Sciences asymptomatic saliva-based PCR testing to its customers. 


"We have been searching for a partnership like this for several months and we are pleased to bring DrugSmart and Travel Health Now into our supply chain," said Mike Kuzmickas, Chief Executive Officer of Ichor. "With our recent Air Canada approval for travel testing to Hawaii, ongoing testing for travel to China and Barbados, as well as a growing corporate testing program, it was critical to establish reliable operations in Ontario to support growing demand. This new partnership is expected to add an additional 120-150 saliva collections per day to our capacity."


DrugSmart and Travel Health Now operate brick and mortar locations in the Toronto, Ottawa, Peterborough, and Kingston areas, as well as a comprehensive virtual service platform that includes a virtual "walk in" clinic, same day local delivery, virtual pharmacy, and much more.




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities